- Home
- LUMO vs MNDO Comparison
LUMO vs MNDO Comparison
Compare LUMO & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMO
- MNDO
- Stock Information
- Founded
- LUMO 2011
- MNDO 1995
- Country
- LUMO United States
- MNDO Israel
- Employees
- LUMO N/A
- MNDO N/A
- Industry
- LUMO Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- LUMO Health Care
- MNDO Technology
- Exchange
- LUMO Nasdaq
- MNDO Nasdaq
- Market Cap
- LUMO 37.7M
- MNDO 39.8M
- IPO Year
- LUMO N/A
- MNDO 2000
- Fundamental
- Price
- LUMO $4.33
- MNDO $1.95
- Analyst Decision
- LUMO Buy
- MNDO
- Analyst Count
- LUMO 4
- MNDO 0
- Target Price
- LUMO $9.38
- MNDO N/A
- AVG Volume (30 Days)
- LUMO 126.3K
- MNDO 22.7K
- Earning Date
- LUMO 11-07-2024
- MNDO 11-05-2024
- Dividend Yield
- LUMO N/A
- MNDO 12.50%
- EPS Growth
- LUMO N/A
- MNDO N/A
- EPS
- LUMO N/A
- MNDO 0.23
- Revenue
- LUMO $2,205,000.00
- MNDO $21,856,000.00
- Revenue This Year
- LUMO $184.11
- MNDO N/A
- Revenue Next Year
- LUMO N/A
- MNDO N/A
- P/E Ratio
- LUMO N/A
- MNDO $8.61
- Revenue Growth
- LUMO 300.59
- MNDO 2.27
- 52 Week Low
- LUMO $1.37
- MNDO $1.70
- 52 Week High
- LUMO $4.58
- MNDO $2.28
- Technical
- Relative Strength Index (RSI)
- LUMO 56.58
- MNDO 48.83
- Support Level
- LUMO $4.25
- MNDO $1.95
- Resistance Level
- LUMO $4.44
- MNDO $2.00
- Average True Range (ATR)
- LUMO 0.12
- MNDO 0.03
- MACD
- LUMO -0.03
- MNDO -0.00
- Stochastic Oscillator
- LUMO 33.33
- MNDO 60.00
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.